propranolol has been researched along with exenatide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bennett, T; Gardiner, SM; Kemp, PA; March, JE | 1 |
1 review(s) available for propranolol and exenatide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for propranolol and exenatide
| Article | Year |
|---|---|
Autonomic nervous system-dependent and -independent cardiovascular effects of exendin-4 infusion in conscious rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Autonomic Nervous System; Blood Glucose; Cardiovascular System; Cyclooxygenase Inhibitors; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Exenatide; Ganglionic Blockers; Hindlimb; Hypoglycemic Agents; Infusions, Intravenous; Male; Peptides; Phentolamine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Receptors, Vasopressin; Regional Blood Flow; Venoms | 2008 |